T. Conroy

1.2k total citations
22 papers, 919 citations indexed

About

T. Conroy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, T. Conroy has authored 22 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Surgery. Recurrent topics in T. Conroy's work include Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (5 papers) and Cancer Treatment and Pharmacology (3 papers). T. Conroy is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (5 papers) and Cancer Treatment and Pharmacology (3 papers). T. Conroy collaborates with scholars based in France, Belgium and Netherlands. T. Conroy's co-authors include Serge Leyvraz, Harry Bleiberg, M. Fickers, D. J. Th. Wagener, H. E. Reis, Marc Buyse, H. O. Klein, J. Wils, F.W. Korsten and Élisabeth Luporsi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

T. Conroy

22 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Conroy France	10	457	456	365	221	194	22	919
M. Hoffmann Austria	12	214 0.5×	159 0.3×	119 0.3×	112 0.5×	518 2.7×	20	674
J M Burgers France	9	167 0.4×	388 0.9×	115 0.3×	121 0.5×	488 2.5×	10	706
Alvin M. Panahon United States	12	178 0.4×	227 0.5×	264 0.7×	194 0.9×	438 2.3×	16	806
Núria Laínez Spain	16	327 0.7×	672 1.5×	432 1.2×	106 0.5×	81 0.4×	77	1.1k
T. Chua Canada	13	338 0.7×	268 0.6×	321 0.9×	204 0.9×	627 3.2×	16	906
Ayman Allam Saudi Arabia	17	214 0.5×	409 0.9×	165 0.5×	106 0.5×	111 0.6×	31	804
R. Otter Netherlands	9	209 0.5×	102 0.2×	87 0.2×	66 0.3×	265 1.4×	10	397
Jens Jakob Germany	15	491 1.1×	994 2.2×	402 1.1×	107 0.5×	88 0.5×	68	1.2k
Harun Badakhshi Germany	18	164 0.4×	397 0.9×	394 1.1×	164 0.7×	72 0.4×	71	961
Lucio Trodella Italy	22	721 1.6×	878 1.9×	535 1.5×	31 0.1×	34 0.2×	68	1.5k

Countries citing papers authored by T. Conroy

Since Specialization

Citations

This map shows the geographic impact of T. Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Conroy more than expected).

Fields of papers citing papers by T. Conroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Conroy. The network helps show where T. Conroy may publish in the future.

Co-authorship network of co-authors of T. Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of T. Conroy. A scholar is included among the top collaborators of T. Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Conroy. T. Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jouve, J L, Pierre Michel, C. Mariette, et al.. (2008). Outcome of the nonrandomized patients in the FFCD 9102 trial: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus. Journal of Clinical Oncology. 26(15_suppl). 4555–4555. 14 indexed citations

Conroy, T., Y. Yataghene, Pierre Étienne, et al.. (2007). Definitive chemo-radiotherapy (CRT) with folfox 4 or 5FU-cisplatin as first line treatment for patients (pts) with inoperable esophageal cancer (IEC): Final results of a randomized phase II study. Journal of Clinical Oncology. 25(18_suppl). 4532–4532. 4 indexed citations

Poinsot, Rollon, T. Conroy, Alexia Savignoni, et al.. (2006). [Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment].. PubMed. 93(3). 315–27. 39 indexed citations

Brédart, Anne, Anne Rousseau, Sylvie Dolbeault, et al.. (2005). [Cancer patient's satisfaction assessment using the EORTC QLQ-SAT32: comparison between self-assessment and interview response].. PubMed. 53 Spec No 1. 1S31–8. 2 indexed citations

Efficace, Fabio, Andrew Bottomley, Corneel Coens, et al.. (2005). The value of patient-reported symptoms as prognostic factors for survival in advanced colorectal cancer. Journal of Clinical Oncology. 23(16_suppl). 3585–3585. 1 indexed citations

Gérard, Jean‐Pierre, P. Romestaing, Franck Bonnetain, et al.. (2005). Preoperative Chemoradiotherapy (CT-RT) Improves Local Control in T3-4 Rectal Cancers: Results of the FFCD 9203 Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 63. S2–S3. 15 indexed citations

Giovannini, Marco, T. Conroy, Éric François, et al.. (2004). Phase I study of first line radiochemotherapy (RCT) with oxaliplatin (Ox), fluorouracil (FU) and folinic acid (FA) in inoperable locally advanced (LA) or metastatic (m) esophageal cancer (EC). Journal of Clinical Oncology. 22(14_suppl). 4044–4044. 1 indexed citations

Ychou, Marc, L. Bosquet, Jacqueline Duffour, et al.. (2004). Recommandations pour la pratique clinique : standards, options et recommandations 2004 pour la prise en charge par radiothérapie des patients atteints d'adénocarcinomes de l'estomac (cancers du cardia, autres types histologiques exclus). Cancer/Radiothérapie. 8(5). 322–335. 4 indexed citations

Vickery, C W, Jane Blazeby, T. Conroy, C D Johnson, & Derek Alderson. (2000). Development of an EORTC module to improve quality of life assessment in patients with gastric cancer. British journal of surgery. 87(3). 365–365. 27 indexed citations

10.

Seitz, Jean‐François, C Milan, J.-M. Cauvin, et al.. (2000). [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].. PubMed. 24(2). 201–10. 19 indexed citations

11.

Conroy, T., Élisabeth Luporsi, D. Peiffert, et al.. (1998). Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 42(5). 935–941. 172 indexed citations

12.

Blay, Jean‐Yves, T. Conroy, Christine Chevreau, et al.. (1998). High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.. Journal of Clinical Oncology. 16(3). 864–871. 244 indexed citations

13.

Spaëth, D., et al.. (1997). Phase II studies of two trial regimens of topotecan as second-line single agent therapy in advanced breast cancer. European Journal of Cancer. 33. S158–S158. 5 indexed citations

14.

Hebbar, Mohamed, Jacques Bonneterre, Laurence Vanlemmens, et al.. (1995). Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancer.. PubMed. 5(4). 201–5. 1 indexed citations

15.

Spaëth, D., T. Conroy, I. Krakowski, et al.. (1993). [Long term continuous combination of cisplatin and 5 fluorouracil in advanced breast neoplasms. A retrospective study of 77 patients].. PubMed. 80(4). 351–6. 5 indexed citations

16.

Reichert, S., et al.. (1993). [Double paraneoplastic syndrome in a case of adenocarcinoma of the endometrium associated with Sezary syndrome].. PubMed. 22(29). 1368–9. 1 indexed citations

17.

Conroy, T., et al.. (1992). Late cardiopulmonary toxicity after treatment for Hodgkin's disease. British Journal of Cancer. 65(6). 908–912. 25 indexed citations

18.

Platini, Christian, et al.. (1992). [Chemotherapy of malignant ovarian Brenner tumors. Review of the literature apropos of 2 histological complete remissions after polychemotherapy].. PubMed. 79(10). 963–7. 1 indexed citations

19.

Wils, J., H. O. Klein, D. J. Th. Wagener, et al.. (1991). Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.. Journal of Clinical Oncology. 9(5). 827–831. 312 indexed citations

20.

Stinès, J, et al.. (1987). [Pseudolinitis plastica of breast origin].. PubMed. 68(4). 269–74. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact